Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
- 1 February 1995
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (2) , 366-370
- https://doi.org/10.1038/bjc.1995.74
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Thoracic Radiation Therapy Alone Compared with Combined Chemoradiotherapy for Locally Unresectable Non-Small Cell Lung CancerAnnals of Internal Medicine, 1991
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI Journal of the National Cancer Institute, 1991
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- Patterns of Mediastinal Metastases in Bronchogenic CarcinomaChest, 1986
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982
- Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage SchedulesAnnals of Internal Medicine, 1981
- Reporting results of cancer treatmentCancer, 1981